Next-generation sequencing in precision oncology: Patient understanding and expectations

scientific article published on 01 January 2019

Next-generation sequencing in precision oncology: Patient understanding and expectations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CAM4.1947
P932PMC publication ID6346219
P698PubMed publication ID30600607

P50authorBrian J Zikmund-FisherQ40392300
Scott RobertsQ88083206
Michele GornickQ88684063
P2093author name stringArul M Chinnaiyan
Lan Q Le
MI-ONCOSEQ Study team
Natalie J Bartnik
P2860cites workA new initiative on precision medicineQ29615654
Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patientsQ30591763
Quality of informed consent: a new measure of understanding among research subjectsQ33935042
Return of genomic results to research participants: the floor, the ceiling, and the choices in betweenQ34000877
Communicating genetic and genomic information: health literacy and numeracy considerationsQ34017520
Personalized oncology through integrative high-throughput sequencing: a pilot studyQ34237470
Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethicsQ34501849
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic MedicineQ34526631
Have we asked too much of consent?Q34598781
Effects of informed consent for individual genome sequencing on relevant knowledgeQ36312837
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthQ36592140
Ethical issues with newborn screening in the genomics eraQ36761963
Development and clinical application of an integrative genomic approach to personalized cancer therapyQ36954557
Harm, hype and evidence: ELSI research and policy guidanceQ36998724
Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicineQ37508612
Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.Q38840660
The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy.Q42204343
Phase I oncology trials: why the therapeutic misconception will not go awayQ43245965
The Limits of Informed Consent for an Overwhelmed Patient: Clinicians' Role in Protecting Patients and Preventing OverwhelmQ47389686
Integrative clinical genomics of metastatic cancerQ48267403
When "Actionable" Genomic Sequencing Results Cannot Be Acted Upon.Q50145151
Understanding the 'therapeutic misconception' from the research participant's perspectiveQ50213573
Validation of a decision regret scaleQ51019738
Value-based genomics.Q55339672
The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing resultsQ57907556
Toward greater understanding of patient decision-making around genome sequencingQ88528819
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)227-237
P577publication date2019-01-01
P1433published inCancer MedicineQ27724564
P1476titleNext-generation sequencing in precision oncology: Patient understanding and expectations
P478volume8

Reverse relations

cites work (P2860)
Q92187870Implementation of Precision Cancer Medicine: Progress and the Path to Realizing the Promise of Tumor Sequencing
Q94585065Metastatic breast cancer patient perceptions of somatic tumor genomic testing
Q90223268Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population
Q92947776The Future of Precision Oncology for the Treatment of Solid Tumors

Search more.